Department of General Courses, School of Management and Medical Information Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
Department of Nutrition, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Int J Clin Pract. 2021 Oct;75(10):e14200. doi: 10.1111/ijcp.14200. Epub 2021 May 2.
Our aim in this meta-analysis was to determine the effect of garlic supplementation on adiponectin and leptin serum levels.
A systematic search was conducted using PubMed, Scopus, ISI Web of Science and Cochrane Library for eligible trials up to November 2020. A fixed-effects model was used to pool calculated effect sizes.
Five trials were included in the overall analysis. Our analysis showed that garlic supplementation did not significantly affect adiponectin (Hedges's: 0.20; 95% CI: -0.06, 0.47; P-values = .12) and leptin (Hedges's: 0.08; 95% CI: -0.26, 0.41; P-values = .65) concentrations in comparison with placebo. However, in the subgroup analysis, significantly increased serum adiponectin level was seen following garlic supplementation in trials with a mean age of participants ˂30 years (Hedges's: 0.44; 95% CI: 0.01, 0.87; P-values = .04), the doses ˂1.5 g/d (Hedges's: 0.38; 95% CI: 0.02, 0.71; P-values = .04) and trials with duration ≥8 weeks (Hedges's: 0.48; 95% CI: 0.08, 0.89; P-values = .02).
Overall, garlic supplementation could not change the circulatory adiponectin and leptin levels. Subgroup analyses showed a significant reduction in adiponectin levels in younger participants, longer duration and lower intervention dose. However, further studies are needed to confirm the present results.
本荟萃分析旨在确定大蒜补充剂对脂联素和瘦素血清水平的影响。
我们对 PubMed、Scopus、ISI Web of Science 和 Cochrane Library 进行了系统检索,以获取截至 2020 年 11 月的合格试验。使用固定效应模型来汇总计算的效应量。
共有 5 项试验纳入了总体分析。我们的分析表明,与安慰剂相比,大蒜补充剂对脂联素(Hedges's:0.20;95% CI:-0.06,0.47;P 值=0.12)和瘦素(Hedges's:0.08;95% CI:-0.26,0.41;P 值=0.65)浓度没有显著影响。然而,在亚组分析中,在参与者平均年龄<30 岁的试验中,大蒜补充剂后血清脂联素水平显著升高(Hedges's:0.44;95% CI:0.01,0.87;P 值=0.04)、剂量<1.5 g/d(Hedges's:0.38;95% CI:0.02,0.71;P 值=0.04)和持续时间≥8 周的试验(Hedges's:0.48;95% CI:0.08,0.89;P 值=0.02)。
总体而言,大蒜补充剂不能改变循环脂联素和瘦素水平。亚组分析显示,在年轻参与者、持续时间更长和干预剂量更低的情况下,脂联素水平显著降低。然而,需要进一步的研究来证实目前的结果。